LV10098B - Methylpiperazinoazepine derivatives, preparation and use thereof - Google Patents
Methylpiperazinoazepine derivatives, preparation and use thereof Download PDFInfo
- Publication number
- LV10098B LV10098B LVP-92-398A LV920398A LV10098B LV 10098 B LV10098 B LV 10098B LV 920398 A LV920398 A LV 920398A LV 10098 B LV10098 B LV 10098B
- Authority
- LV
- Latvia
- Prior art keywords
- methylpiperazin
- benzo
- pyrido
- diazepine
- est
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D517/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms
- C07D517/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms in which the condensed system contains two hetero rings
- C07D517/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE9000914A BE1004596A4 (fr) | 1990-09-26 | 1990-09-26 | Derives de methylpiperazinoazepine, leur preparation et leur utilisation. |
CA002120229A CA2120229C (fr) | 1990-09-26 | 1991-10-10 | Derives de methylpiperazinoazepine, leur preparation et leur utilisation |
PCT/BE1991/000073 WO1993007143A1 (fr) | 1990-09-26 | 1991-10-10 | Derives de methylpiperazinoazepine, leur preparation et leur utilisation |
HK98106195A HK1006970A1 (en) | 1990-09-26 | 1998-06-23 | Methylpiperazinoazepine derivatives their preparation and use |
Publications (2)
Publication Number | Publication Date |
---|---|
LV10098A LV10098A (lv) | 1994-05-10 |
LV10098B true LV10098B (en) | 1994-10-20 |
Family
ID=27159764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LVP-92-398A LV10098B (en) | 1990-09-26 | 1992-12-23 | Methylpiperazinoazepine derivatives, preparation and use thereof |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0607129B1 (xx) |
AT (1) | ATE126799T1 (xx) |
BE (1) | BE1004596A4 (xx) |
CA (1) | CA2120229C (xx) |
DE (1) | DE69112432T2 (xx) |
DK (1) | DK0607129T3 (xx) |
EE (1) | EE02942B1 (xx) |
ES (1) | ES2080336T3 (xx) |
GR (1) | GR3017951T3 (xx) |
HK (1) | HK1006970A1 (xx) |
LT (1) | LT3231B (xx) |
LV (1) | LV10098B (xx) |
RU (1) | RU2111966C1 (xx) |
WO (1) | WO1993007143A1 (xx) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5700445A (en) * | 1994-12-12 | 1997-12-23 | Allelix Biopharmaceuticals, Inc. | N-methyl piperazine compounds having dopamine receptor affinity |
US5561127A (en) * | 1994-12-19 | 1996-10-01 | Allelix Biopharmaceuticals, Inc. | Muscarinic receptor ligands |
FR2850654A1 (fr) * | 2003-02-03 | 2004-08-06 | Servier Lab | Nouveaux derives d'azepines tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
CN1913900B (zh) * | 2003-12-22 | 2010-11-24 | 阿卡蒂亚药品公司 | 作为毒蕈碱激动剂的氨基取代的二芳基[a,d]环庚烯类似物及神经精神疾病的治疗方法 |
US7550454B2 (en) | 2003-12-22 | 2009-06-23 | Acadia Pharmaceuticals, Inc. | Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
CN102807574B (zh) * | 2011-05-30 | 2015-09-02 | 长春吉大天元化学技术股份有限公司 | 新型吡啶并硫氮七元环衍生物作为抗肿瘤药物、及其制备方法和应用 |
CN107382907A (zh) * | 2017-06-21 | 2017-11-24 | 温州医科大学 | 一种11‑甲基二苯并[b,f][1,4]硒吖庚因化合物及制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7403657A (xx) * | 1973-03-23 | 1974-09-25 | ||
US3872122A (en) * | 1973-04-16 | 1975-03-18 | Bristol Myers Co | 11 H-Pyrimido{8 4,5-b{9 {8 1,4{9 benzodiazepines |
GB1587128A (en) | 1977-04-07 | 1981-04-01 | Hexachimie | Benzothiazepine derivatives |
IT7851496A0 (it) * | 1977-10-31 | 1978-10-13 | Sandoz Ag | Menti pirazinobenzossazepine loro preparazione e loro impiego quali medica |
CH643263A5 (de) * | 1979-05-11 | 1984-05-30 | Sandoz Ag | Benzodiazepine, ihre herstellung und verwendung. |
GB8819059D0 (en) * | 1988-08-11 | 1988-09-14 | Lilly Industries Ltd | Benzodiazepine compounds & their use as pharmaceuticals |
US4940704A (en) | 1989-08-16 | 1990-07-10 | Hoechst-Roussel Pharmaceutical Inc. | Pyrido[3,4-b][1,4]benzoxazepines |
-
1990
- 1990-09-26 BE BE9000914A patent/BE1004596A4/fr not_active IP Right Cessation
-
1991
- 1991-10-10 RU RU94021365A patent/RU2111966C1/ru not_active IP Right Cessation
- 1991-10-10 CA CA002120229A patent/CA2120229C/fr not_active Expired - Fee Related
- 1991-10-10 ES ES91916897T patent/ES2080336T3/es not_active Expired - Lifetime
- 1991-10-10 DE DE69112432T patent/DE69112432T2/de not_active Expired - Fee Related
- 1991-10-10 AT AT91916897T patent/ATE126799T1/de not_active IP Right Cessation
- 1991-10-10 WO PCT/BE1991/000073 patent/WO1993007143A1/fr active IP Right Grant
- 1991-10-10 DK DK91916897.1T patent/DK0607129T3/da active
- 1991-10-10 EP EP91916897A patent/EP0607129B1/fr not_active Expired - Lifetime
-
1992
- 1992-12-23 LV LVP-92-398A patent/LV10098B/lv unknown
-
1993
- 1993-03-03 LT LTIP378A patent/LT3231B/lt not_active IP Right Cessation
-
1994
- 1994-10-14 EE EE9400260A patent/EE02942B1/xx not_active IP Right Cessation
-
1995
- 1995-11-01 GR GR950403060T patent/GR3017951T3/el unknown
-
1998
- 1998-06-23 HK HK98106195A patent/HK1006970A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EE02942B1 (et) | 1996-10-15 |
DE69112432T2 (de) | 1996-02-01 |
HK1006970A1 (en) | 1999-03-26 |
CA2120229A1 (fr) | 1993-04-15 |
EP0607129B1 (fr) | 1995-08-23 |
LV10098A (lv) | 1994-05-10 |
GR3017951T3 (en) | 1996-02-29 |
LTIP378A (en) | 1994-09-25 |
EP0607129A1 (fr) | 1994-07-27 |
WO1993007143A1 (fr) | 1993-04-15 |
BE1004596A4 (fr) | 1992-12-22 |
ES2080336T3 (es) | 1996-02-01 |
DK0607129T3 (da) | 1995-12-18 |
DE69112432D1 (de) | 1995-09-28 |
CA2120229C (fr) | 2002-04-09 |
LT3231B (en) | 1995-04-25 |
RU2111966C1 (ru) | 1998-05-27 |
ATE126799T1 (de) | 1995-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4062848A (en) | Tetracyclic compounds | |
EP0281459B1 (fr) | Enantiomère dextrogyre de l'alpha-(tétrahydro-4,5,6,7 thiéno (3,2-c)pyridyl-5) (chloro-2 phényl)-acétate de méthyle, son procédé de préparation et les compositions pharmaceutiques le renfermant | |
EP0587473B1 (fr) | Dérivés condensés de la pyridine comme inhibiteurs de l'effet des radicaux libres | |
DK164704B (da) | 3,6-disubstituerede triazolo-oe3,4-aaa-ftalazinderivater, fremgangsmaade til fremstilling deraf, udgangsforbindelse til anvendelse i fremgangsmaaden samt anvendelse af og farmaceutisk praeparat indeholdende forbindelserne | |
US5393752A (en) | Methylpiperazinoazepine compounds, preparation and use thereof | |
CA2468071A1 (fr) | Derives de triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-ones, compositions les contenant, procede de preparation et utilisation | |
LV10098B (en) | Methylpiperazinoazepine derivatives, preparation and use thereof | |
CS219256B2 (en) | Method of making the derivative of the imidazothienpyrimidine | |
EA002271B1 (ru) | ТРИЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ, ОБЛАДАЮЩИЕ АКТИВНОСТЬЮ В ОТНОШЕНИИ ИНТЕГРИНОВ, В ЧАСТНОСТИ В ОТНОШЕНИИ ИНТЕГРИНА АЛЬФАvБЕТА 3, СПОСОБ ИХ ПОЛУЧЕНИЯ И ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ, ИСПОЛЬЗУЕМЫЕ В ЭТОМ СПОСОБЕ, ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ МЕДИКАМЕНТОВ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ | |
DK150157B (da) | Analogifremgangsmaade til fremstilling af furo-, thieno- eller pyrrolo (2,3-d)azepiner eller fysiologisk acceptable salte deraf med syrer eller baser | |
EP0662971B1 (fr) | DERIVES DE 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-4-ONE, LEUR PREPARATION ET LES MEDICAMENTS LES CONTENANT | |
CZ295992B6 (cs) | Beta-karbolinové deriváty, způsob jejich přípravy a farmaceutické prostředky s jejich obsahem | |
EP0971928A1 (fr) | Derives de quinolein-2(1h)-one et de dihydroquinolein-2(1h)-one en tant que lingands des recepteurs 5-ht, 5-ht2 et 5-ht1-like | |
US7053083B2 (en) | Cyclohexylphenyl vasopressin agonists | |
CS203184B2 (en) | Process for preparing new pyrroloquinoxalinones and pyrrolobenzodiazepinones | |
JP2752516B2 (ja) | メチルピペラジノアゼピン誘導体およびこれを含有した組成物 | |
EP0499527B1 (fr) | Composés dérivés des beta-carbolines ligands du récepteur des benzodiazépines ayant un effet agoniste inverse et antagoniste vis-à-vis des benzodiazépines et médicaments les contenant | |
AU597936B2 (en) | Tetracyclic quinazolin derivatives | |
BRPI0312174B1 (pt) | composto, composição farmacêutica, uso de um composto, processo para a preparação de um composto, novo intermediário e processo para a preparação de um novo intermediário | |
CA2415475C (en) | Pyrrolo[2,1-b][1,3]benzothiazepines and their use for the preparation of medicaments with antipsychotic activity | |
EP0726257B1 (en) | 1-(Hetero)Arylvinyl-5H-2,3-benzodiazepine derivatives useful for the treatment of central nervous system disorders, and benzopyrylium intermediates for their preparation | |
JP3128750B2 (ja) | 1−[2−(置換ビニル)]−5h−2,3−ベンゾジアゼピン誘導体 | |
IE873252L (en) | Pyrrole derivatives. | |
KR910005853B1 (ko) | 벤조티오피라노[4,3-c]피리다진 화합물의 제조방법 | |
PT91498B (pt) | Processo para preparacao de acidos e esteres quinolonocarboxilicos azabiciclicos em ponte amino-substituidos |